Temozolomide Capsule
Product Images NDC 31722-416

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 31722-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temozolamidecapsules100mg5scountcartonlabel (Temozolamidecapsules100mg5scountcartonlabel)

Packaging label for Temozolomide Capsules, USP 100 mg, an oral prescription drug by Camber Pharmaceuticals, Inc. The label states 5 capsules per package with warnings for pharmacists and cytotoxic instructions. It includes storage conditions and a U.S. contact number. Manufactured for Camber Pharmaceuticals and by Hetero Labs Limited, India. NDC 31722-413-31.*

FDA Label Image

Temozolamidecapsules100mg5scountcontainerlabel (Temozolamidecapsules100mg5scountcontainerlabel)

Label for Temozolomide Capsules, USP 100 mg by Camber Pharmaceuticals, Inc. The label shows product name, strength (100 mg), oral dosage form, and quantity (5 capsules). It includes usage instructions, storage temperature (20° to 25°C), cytotoxic warnings, and contact information, alongside a barcode and manufacturer details (Hetero Labs Limited, India).*

FDA Label Image

Temozolamidecapsules140mg5scountcartonlabel (Temozolamidecapsules140mg5scountcartonlabel)

Packaging label for Temozolomide Capsules, USP 140 mg, manufactured by Camber Pharmaceuticals, Inc. The label indicates oral administration, Rx only, and contains 5 capsules per package. It includes safety and storage instructions, pharmacist dispensing information, and manufacturing details including a barcode and contact information.*

FDA Label Image

Temozolamidecapsules140mg5scountcontainerlabel (Temozolamidecapsules140mg5scountcontainerlabel)

Label for Temozolomide Capsules, USP 140 mg by Camber Pharmaceuticals, Inc. The label states the product is for oral administration, contains 5 capsules, and includes usage warnings such as cytotoxicity and storage conditions at 20° to 25°C. The label features a barcode, contact number, and manufacturing information by Hetero Labs Limited, India.*

FDA Label Image

Temozolamidecapsules180mg5scountcartonlabel (Temozolamidecapsules180mg5scountcartonlabel)

Packaging label for TEMOZOLOMIDE Capsules, USP 180 mg, by Camber Pharmaceuticals, Inc. The label indicates the product is for oral administration, prescription only, containing 5 capsules per package. It includes dosing instructions, storage recommendations, and a U.S. contact number. The label also notes special instructions for pharmacists and manufacturing information including the Indian manufacturer Hetero Labs Limited.*

FDA Label Image

Temozolamidecapsules180mg5scountcontainerlabel (Temozolamidecapsules180mg5scountcontainerlabel)

Label for Temozolomide Capsules USP 180 mg by Camber Pharmaceuticals, Inc. The label states the capsules are for oral administration and come in a package containing 5 capsules. It includes dosage instructions to see package insert and storage instructions for controlled room temperature (20° to 25°C). The label cautions the drug as cytotoxic and advises not to open capsules. Manufacturer information includes Hetero Labs Limited in India. A barcode and U.S. contact number are also visible.*

FDA Label Image

Temozolamidecapsules20mg5scountcartonlabel (Temozolamidecapsules20mg5scountcartonlabel)

Carton label for Temozolomide Capsules, USP 20 mg by Camber Pharmaceuticals, Inc. The label features the product name, dosage strength of 20 mg, and quantity of 5 capsules. It includes storage instructions, cytotoxicity warnings, and a U.S. contact number. Manufactured for Camber Pharmaceuticals, Piscataway, NJ, and produced by Hetero Labs Limited in India. Barcode and NDC 31722-412-31 are visible.*

FDA Label Image

Temozolamidecapsules20mg5scountcontainerlabel (Temozolamidecapsules20mg5scountcontainerlabel)

Label for Temozolomide Capsules, USP 20 mg by Camber Pharmaceuticals, Inc. The label states oral administration, contains 5 capsules, and includes storage instructions and a U.S. contact number. The NDC is 31722-412-31. The product is manufactured by Hetero Labs Limited, India, for Camber Pharmaceuticals in New Jersey.*

FDA Label Image

Temozolamidecapsules250mg5scountcartonlabel (Temozolamidecapsules250mg5scountcartonlabel)

Box label for Temozolomide Capsules, USP 250 mg by Camber Pharmaceuticals, Inc. The label displays the product name, strength, dosage form, route as oral administration, package size of 5 capsules, and includes pharmacist instructions, storage information, and manufacturer contact details. Barcode and batch coding instructions are also shown.*

FDA Label Image

Temozolamidecapsules250mg5scountcontainerlabel (Temozolamidecapsules250mg5scountcontainerlabel)

TEMOZOLOMIDE 250 mg Capsules, USP label from Camber Pharmaceuticals, Inc. The label indicates oral administration and a package size of 5 capsules. It includes storage instructions, cytotoxic warnings, a barcode, and manufacturer details with contact information.*

FDA Label Image

Temozolamidecapsules5mg5scountcartonlabel (Temozolamidecapsules5mg5scountcartonlabel)

Packaging label for Temozolomide Capsules, USP 5 mg by Camber Pharmaceuticals, Inc., NDC 31722-411-31. The label highlights capsule strength, oral administration, a 5-capsule count, storage instructions, cytotoxic warning, pharmacist attention note, manufacturer details, and a barcode.*

FDA Label Image

Temozolamidecapsules5mg5scountcontainerlabel (Temozolamidecapsules5mg5scountcontainerlabel)

Label for Temozolomide Capsules USP 5 mg oral capsules by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-411-31, storage instructions at 20° to 25°C, and warnings not to open capsules, and to swallow whole. The package contains 5 capsules and provides a U.S. contact number for questions.*

FDA Label Image

Temozolamidecapsulescamberlogo (Temozolamidecapsulescamberlogo)

FDA Label Image

Temozolamidecapsulesfigure1 (Temozolamidecapsulesfigure1)

A Kaplan-Meier survival curve showing overall survival percentage over time in months for two treatment arms: RT + TMZ (radiotherapy plus temozolomide) and RT Only (radiotherapy alone). The graph includes the number of patients at risk over time for each group. The RT + TMZ group shows higher survival rates across the timeline compared to RT Only.*

FDA Label Image

Temozolamidecapsulesstructure (Temozolamidecapsulesstructure)

Chemical structure of temozolomide, showing its ring system with nitrogen atoms, methyl group, and carbonyl and amide functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.